Tantalus revisited--the search for the ideal anti-thrombotic dose of aspirin.
作者信息
Deykin D, Jakubowski J A, Stampfer M J, Faigel D
出版信息
Trans Am Clin Climatol Assoc. 1987;98:167-75.
Abstract
摘要
相似文献
1
Tantalus revisited--the search for the ideal anti-thrombotic dose of aspirin.重访坦塔罗斯——探寻阿司匹林的理想抗血栓剂量
Trans Am Clin Climatol Assoc. 1987;98:167-75.
2
Optimal dose for starting and maintaining low-dose aspirin.起始和维持低剂量阿司匹林的最佳剂量。
Arch Intern Med. 1993 Mar 22;153(6):700-2.
3
Aspirin and the prevention of experimental arterial thrombosis: difficulty in establishing unequivocal effectiveness.阿司匹林与实验性动脉血栓形成的预防：难以确定其确切疗效。
Thromb Haemost. 1985 Oct 30;54(3):619-21.
4
5
The aspirin dilemma revisited.再探阿司匹林困境。
N Engl J Med. 1984 May 17;310(20):1326-7. doi: 10.1056/NEJM198405173102014.
6
Aspirin and thrombosis in patients undergoing hemodialysis.接受血液透析患者的阿司匹林与血栓形成
N Engl J Med. 1980 Jun 19;302(25):1420-1. doi: 10.1056/NEJM198006193022515.
7
A prospective analysis of thrombotic events in the European collaboration study on low-dose aspirin in polycythemia (ECLAP).欧洲真性红细胞增多症低剂量阿司匹林协作研究（ECLAP）中血栓形成事件的前瞻性分析。
Pathol Biol (Paris). 2004 Jun;52(5):285-8. doi: 10.1016/j.patbio.2004.02.007.
8
Survival of heparins, oral anticoagulants, and aspirin after the year 2010.2010年后肝素、口服抗凝剂及阿司匹林的生存情况。
Semin Thromb Hemost. 2008 Feb;34(1):58-73. doi: 10.1055/s-2008-1066025.
9
Aspirin for the control of platelet activation and prevention of thrombosis in essential thrombocythemia and polycythemia vera: current insights and rationale for future studies.阿司匹林用于控制原发性血小板增多症和真性红细胞增多症中的血小板活化及预防血栓形成：当前见解及未来研究的理论依据
Semin Thromb Hemost. 2006 Apr;32(3):251-9. doi: 10.1055/s-2006-939436.
10
Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis.选择性因子Xa抑制剂PD0348292与抗血小板药物对动脉血栓形成抑制作用的比较。
Thromb Haemost. 2008 Apr;99(4):759-66. doi: 10.1160/TH07-09-0576.
本文引用的文献
1
Identification of membrane proteins mediating the interaction of human platelets.介导人血小板相互作用的膜蛋白的鉴定
J Cell Biol. 1980 Jul;86(1):77-86. doi: 10.1083/jcb.86.1.77.
2
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.阿司匹林长期给药期间人体中前列环素和血栓素的内源性生物合成及血小板功能
J Clin Invest. 1983 Mar;71(3):676-88. doi: 10.1172/jci110814.
3
Arachidonate metabolism in vascular disorders.血管疾病中的花生四烯酸代谢
J Clin Invest. 1983 Nov;72(5):1521-5. doi: 10.1172/JCI111110.
4
The relationship between the plasma concentration of free nicotinic acid and some of its pharmacologic effects in man.人体中游离烟酸的血浆浓度与其某些药理作用之间的关系。
Clin Pharmacol Ther. 1969 Jul-Aug;10(4):559-70. doi: 10.1002/cpt1969104559.
5
Prostaglandins and nicotinate-provoked increase in cutaneous blood flow.前列腺素和烟酸引起皮肤血流量增加。
Clin Pharmacol Ther. 1985 Sep;38(3):273-7. doi: 10.1038/clpt.1985.170.
6
The 2 x 2 factorial design: its application to a randomized trial of aspirin and carotene in U.S. physicians.2×2析因设计：其在美国医生中进行的阿司匹林与胡萝卜素随机试验中的应用。
Stat Med. 1985 Apr-Jun;4(2):111-6. doi: 10.1002/sim.4780040202.
7
Cumulative antiplatelet effect of low-dose enteric coated aspirin.小剂量肠溶阿司匹林的累积抗血小板作用
Br J Haematol. 1985 Aug;60(4):635-42. doi: 10.1111/j.1365-2141.1985.tb07467.x.
8
Locally acting growth factors for vascular smooth muscle cells: endogenous synthesis and release from platelets.血管平滑肌细胞的局部作用生长因子：内源性合成及血小板释放
Circulation. 1985 Oct;72(4):735-40. doi: 10.1161/01.cir.72.4.735.
9
Platelet activation in unstable coronary disease.不稳定型冠心病中的血小板活化
N Engl J Med. 1986 Oct 16;315(16):983-9. doi: 10.1056/NEJM198610163151602.
10
Effect of alternate-day regular and enteric-coated aspirin on platelet aggregation, bleeding time, and thromboxane A2 levels in bleeding-time blood.隔日服用普通阿司匹林和肠溶阿司匹林对出血时间血液中血小板聚集、出血时间及血栓素A2水平的影响
Am J Med. 1986 Sep;81(3):400-4. doi: 10.1016/0002-9343(86)90289-5.
Zotero 插件